Patrick Truesdell
Net worth: - $ as of 31/03/2024
Profile
Patrick Truesdell served as Chief Accounting Officer, VP & Controller at Landos Biopharma, Inc. from 2022 to 2023.
Prior to that, he was Vice President-Finance & Controller at Gemini Therapeutics, Inc. from 2021 to 2022.
Truesdell received a graduate degree from the University of Illinois and undergraduate and MBA degrees from Tippie College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 30/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Former positions of Patrick Truesdell
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Investor Relations Contact | 10/11/2023 |
| GEMI THER | Comptroller/Controller/Auditor | 01/04/2022 |
Training of Patrick Truesdell
| University of Illinois | Graduate Degree |
| Tippie College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Patrick Truesdell
